2-Bromo-α-ergocryptine, Methanesulfonate, BRC, BCT
For general questions please contact our Customer Service:
290 Concord Road
01821 Billerica, MA
18 April 2014
This product has been discontinued.
We apologize for the inconvenience, but we do not currently have an alternative product. For related products, please refer to our complete listing of nitric oxide synthase inhibitors.
Dopamine D2 receptor agonist that potently and selectively inhibits neuronal NOS (nNOS; IC50 = 10 µM) by affecting the activation of NOS by calmodulin. Has only a weak inhibitory effect on inducible NOS (iNOS; IC50 > 100 µM). Modulates P-glycoprotein function. Inhibits Mg2+ ATPase activity (IC50 = 300 nM) and verapamil-induced P-glycoprotein ATPase activity (Ki = 200 nM). Also inhibits prolactin secretion.
|Form||Pale yellow powder|
|Primary Target IC50||10 µM|
|Secondary target||iNOS > 100 µM|
|Purity||≥98% by TLC|
|Chemical formula||C32H40BrN5O5 · CH3SO3H|
|Merck USA index||14, 1416|
|Store and ship information|
|Storage||+2°C to +8°C|
Ambient Temperature Only
Carcinogenic / Teratogenic
Wear suitable protective clothing.
Possible risk of impaired fertility.